• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

精神科中合并用药和多药联合使用的历史、背景、概念及当前应用

History, background, concepts and current use of comedication and polypharmacy in psychiatry.

作者信息

Möller H-J, Seemüller F, Schennach-Wolff R, Stübner S, Rüther E, Grohmann R

机构信息

Department of Psychiatry and Psychotherapy,Ludwig-Maximilians-University,Nussbaumstr.7, 80336 Munich,Germany.

Bezirkskrankenhaus Augsburg, Dr-Mack-Straße 1, 86156Augsburg.

出版信息

Int J Neuropsychopharmacol. 2014 Jul;17(7):983-96. doi: 10.1017/S1461145713000837. Epub 2013 Sep 18.

DOI:10.1017/S1461145713000837
PMID:24044761
Abstract

Based on a careful literature search a review is presented of the history, background, concepts and current use of comedication and polypharmacy in psychiatry. The pros and cons of comedication and polypharmacy are presented, as well as their apparent increase in recent times. Possible reasons for the increase of comedication/polypharmacy are described. Both the potential advantages as well as the potential risks are discussed. The one sided view that all comedication/polypharmacy is nothing but problematic is questioned. Comedication/polypharmacy seems to be, among others, the current answer to the well-known limited efficacy and effectiveness of current monotherapy treatment strategies.

摘要

基于全面的文献检索,本文对精神科联合用药和多药联合使用的历史、背景、概念及当前应用进行了综述。阐述了联合用药和多药联合使用的利弊,以及近年来其明显增多的情况。描述了联合用药/多药联合使用增加的可能原因。讨论了潜在的益处和潜在风险。对认为所有联合用药/多药联合使用都存在问题的片面观点提出了质疑。联合用药/多药联合使用似乎是,其中包括,对当前单一疗法治疗策略众所周知的有限疗效的当前应对方法。

相似文献

1
History, background, concepts and current use of comedication and polypharmacy in psychiatry.精神科中合并用药和多药联合使用的历史、背景、概念及当前应用
Int J Neuropsychopharmacol. 2014 Jul;17(7):983-96. doi: 10.1017/S1461145713000837. Epub 2013 Sep 18.
2
Polypharmacy prevalence rates in the treatment of unipolar depression in an outpatient clinic.门诊治疗单相抑郁症中多药治疗的流行率。
J Affect Disord. 2009 Sep;117(1-2):18-23. doi: 10.1016/j.jad.2008.11.016. Epub 2008 Dec 21.
3
National trends in psychotropic medication polypharmacy in office-based psychiatry.基于办公室的精神病学中精神药物联合用药的全国趋势。
Arch Gen Psychiatry. 2010 Jan;67(1):26-36. doi: 10.1001/archgenpsychiatry.2009.175.
4
When is polypharmacy an advantage?何时联合用药具有优势?
Am J Psychiatry. 2011 Jul;168(7):663. doi: 10.1176/appi.ajp.2011.11050695.
5
Poor agreement amongst psychiatrists assessing rationality in five cases of psychiatric polypharmacy.在评估五例精神科联合用药病例的合理性时,精神科医生之间的一致性较差。
Prog Neuropsychopharmacol Biol Psychiatry. 2008 May 15;32(4):1069-71. doi: 10.1016/j.pnpbp.2007.12.008. Epub 2008 Mar 17.
6
On 'polypharmacy' and multi-target agents, complementary strategies for improving the treatment of depression: a comparative appraisal.关于“多药联合治疗”与多靶点药物:改善抑郁症治疗的互补策略:一项比较评估
Int J Neuropsychopharmacol. 2014 Jul;17(7):1009-37. doi: 10.1017/S1461145712001496. Epub 2013 May 30.
7
Prevalence, utilization patterns, and predictors of antipsychotic polypharmacy: experience in a multistate Medicaid population, 1998-2003.抗精神病药物联合使用的患病率、使用模式及预测因素:1998 - 2003年多州医疗补助人群的经验
Clin Ther. 2007 Jan;29(1):183-95. doi: 10.1016/j.clinthera.2007.01.002.
8
A framework to avoid irrational polypharmacy in psychiatry.精神病学中避免不合理多种药物治疗的框架。
J Psychopharmacol. 2012 Dec;26(12):1507-11. doi: 10.1177/0269881112453211. Epub 2012 Jul 5.
9
Polypharmacy in psychiatry: a multi-state comparison of psychotropic drug combinations.精神病学中的多药联合治疗:精神药物组合的多州比较
Dis Nerv Syst. 1974 Apr;35(4):183-9.
10
Polypharmacy with second-generation antipsychotics: a review of evidence.第二代抗精神病药物的联合用药:证据综述
J Psychiatr Pract. 2008 Nov;14(6):345-67. doi: 10.1097/01.pra.0000341890.05383.45.

引用本文的文献

1
Comparative analysis of anticholinergic burden scales to explain iatrogenic cognitive impairment in schizophrenia: results from the multicenter FACE-SZ cohort.抗胆碱能负担量表对精神分裂症医源性认知障碍的比较分析:来自多中心FACE-SZ队列的结果
Front Pharmacol. 2024 Jun 12;15:1403093. doi: 10.3389/fphar.2024.1403093. eCollection 2024.
2
Polypharmacy in psychiatry and weight gain: longitudinal study of 832 patients hospitalized for depression or schizophrenia, along with data of 3180 students from Europe, the U.S., South America, and China.精神科的多药联用与体重增加:对832名因抑郁症或精神分裂症住院患者的纵向研究,以及来自欧洲、美国、南美洲和中国的3180名学生的数据。
Eur Arch Psychiatry Clin Neurosci. 2025 Jun;275(4):1001-1014. doi: 10.1007/s00406-024-01767-2. Epub 2024 Mar 10.
3
How Real-World Data Can Facilitate the Development of Precision Medicine Treatment in Psychiatry.真实世界数据如何促进精神病学精准医疗治疗的发展。
Biol Psychiatry. 2024 Oct 1;96(7):543-551. doi: 10.1016/j.biopsych.2024.01.001. Epub 2024 Jan 5.
4
Climate Change and the Professional Obligation to Socialize Physicians and Trainees into an Environmentally Sustainable Medical Culture.气候变化与将医生和实习生融入环境可持续医学文化的职业义务
Acad Psychiatry. 2022 Oct;46(5):556-561. doi: 10.1007/s40596-022-01688-z.
5
miRNAs as potential diagnostic biomarkers and pharmacogenomic indicators in psychiatric disorders.miRNAs 作为精神障碍的潜在诊断生物标志物和药物基因组学指标。
Pharmacogenomics J. 2022 Jul;22(4):211-222. doi: 10.1038/s41397-022-00283-7. Epub 2022 Jun 20.
6
Detailing the effects of polypharmacy in psychiatry: longitudinal study of 320 patients hospitalized for depression or schizophrenia.详述精神医学中药物滥用的影响:320 例抑郁症或精神分裂症住院患者的纵向研究。
Eur Arch Psychiatry Clin Neurosci. 2022 Jun;272(4):603-619. doi: 10.1007/s00406-021-01358-5. Epub 2021 Nov 25.
7
A Call for a Rational Polypharmacy Policy: International Insights From Psychiatrists.呼吁制定合理的多药联合治疗政策:来自精神科医生的国际见解。
Psychiatry Investig. 2021 Nov;18(11):1058-1067. doi: 10.30773/pi.2021.0169. Epub 2021 Nov 5.
8
Antipsychotic Polypharmacy Is Associated With Adverse Drug Events in Psychiatric Inpatients: The Japan Adverse Drug Events Study.抗精神病药联合用药与精神科住院患者的药物不良事件相关:日本药物不良事件研究。
J Clin Psychopharmacol. 2021;41(4):397-402. doi: 10.1097/JCP.0000000000001416.
9
Multimorbidity and Its Outcomes Among Patients Attending Psychiatric Care Settings: An Observational Study From Odisha, India.精神卫生保健机构就诊患者的多病共存及其结局:来自印度奥里萨邦的一项观察性研究。
Front Public Health. 2021 Apr 21;8:616480. doi: 10.3389/fpubh.2020.616480. eCollection 2020.
10
Predicting the risk of drug-drug interactions in psychiatric hospitals: a retrospective longitudinal pharmacovigilance study.预测精神病医院中药物相互作用的风险:一项回顾性纵向药物警戒研究。
BMJ Open. 2021 Apr 9;11(4):e045276. doi: 10.1136/bmjopen-2020-045276.